Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours

Kristian Almstrup, João Lobo, Nina Mørup, Gazanfer Belge, Ewa Rajpert-De Meyts, Leendert H J Looijenga, Klaus-Peter Dieckmann

Research output: Contribution to journalReview articlepeer-review

Abstract

Testicular germ cell tumours (TGCTs) are the most frequent cancer type in young men and originate from the common precursor germ cell neoplasia in situ (GCNIS). For decades, clinical management of patients with TGCT has relied on classic serum tumour markers: α-fetoprotein, human chorionic gonadotropin subunit-β and lactate dehydrogenase. In the past 10 years, microRNAs have been shown to outperform classic serum tumour markers in the diagnosis of primary tumours and in follow-up monitoring and prediction of relapse. miR-371a-3p is the most consistent marker and exhibits >90% diagnostic sensitivity and specificity in TGCT. However, miR-371a-3p cannot be used to diagnose GCNIS or mature teratoma. Future efforts must technically standardize the microRNA-based methods internationally and introduce miR-371a-3p as a molecular liquid biopsy-based marker for TGCTs in the clinic.

Original languageEnglish
Pages (from-to)201-213
Number of pages13
JournalNature reviews. Urology
Volume17
Issue number4
DOIs
Publication statusPublished - Apr 2020

Keywords

  • Aftercare
  • Biomarkers, Tumor/genetics
  • Chorionic Gonadotropin, beta Subunit, Human/metabolism
  • Humans
  • L-Lactate Dehydrogenase/metabolism
  • Liquid Biopsy
  • Male
  • MicroRNAs/metabolism
  • Neoplasm Recurrence, Local/diagnosis
  • Neoplasms, Germ Cell and Embryonal/diagnosis
  • Seminoma/diagnosis
  • Sensitivity and Specificity
  • Teratoma/diagnosis
  • Testicular Neoplasms/diagnosis
  • alpha-Fetoproteins/metabolism

Fingerprint

Dive into the research topics of 'Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours'. Together they form a unique fingerprint.

Cite this